Quinidine gluconate (quinidine gluonate) NDC 71930-016

NDC codes

FDA NDC Directory

Product NDC (as listed)71930-016Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71930-0016Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71930-016-12	71930001612	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-016-12)Marketed from Mar 20, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Quinidine gluconate
Generic name (nonproprietary): quinidine gluonate
Active ingredients: Quinidine gluconate — 324 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Eywa Pharma Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212589
Marketing start: Mar 20, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)
Identifiers: Product ID 71930-016_d4e8ed08-f426-4fdb-9dd3-d46730e9f81bSPL ID d4e8ed08-f426-4fdb-9dd3-d46730e9f81bSPL set ID 4db375a3-0cff-4fa7-af7a-2a49e0b922d0RxCUI 852920UNII R6875N380FUPC 0371930016127
Pharmacologic class: Antiarrhythmic; Cytochrome P450 2D6 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471930001612 followed by a unit qualifier and the quantity

Package 71930-0016-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 29, 2021.

Indications (excerpt from the label)

INDICATIONS & USAGE Conversion of atrial fibrillation/flutter In patients with symptomatic atrial fibrillation/flutter whose symptoms are not adequately controlled by measures that reduce the rate of ventricular response, quinidine gluconate is indicated as a means of restoring normal sinus rhythm. If this use of quinidine gluconate does not restore sinus rhythm within a reasonable time (see DOSAGE AND ADMINISTRATION ), then quinidine gluconate should be discontinued. Reduction of frequency of relapse into atrial fibrillation/flutter Chronic therapy with quinidine gluconate is indicated for some patients at high risk of symptomatic atrial fibrillation/flutter, generally patients who have had…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)